Cambria Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cambria Investment Management's AMGN Position: Q2 2026 in Review
Cambria Investment Management increased its Amgen (AMGN) stake by 137% in Q2 2026, buying an estimated $1.01M and bringing the position to 5,093 shares worth $1.84M. The position accounts for 0.09% of the portfolio, ranked #207.
Cambria Investment Management first reported a position in AMGN in Q3 2015 and has held it in 15 quarters since. The position peaked at $5.86M in Q4 2017. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cambria Investment Management held 5,093 shares of Amgen worth $1.84M as of Q2 2026.
- Cambria Investment Management bought 2,941 Amgen shares in Q2 2026, an estimated $1.01M.
- Amgen made up 0.09% of Cambria Investment Management's portfolio in Q2 2026, its #207 holding.
- Cambria Investment Management first reported a position in Amgen in Q3 2015 and has held it in 15 quarters since.
- Cambria Investment Management's Amgen position peaked at $5.86M in Q4 2017.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.